Dimerix


Company Announcements:
(reported by the Company)
No items found
Elevator Pitch:

Dimerix Bioscience is a public unlisted clinical stage drug discovery and development company, based in Melbourne. Dimerix’s lead clinical program is a Phase 2 study in Chronic Kidney Disease, DMX-200. This study has repurposing of existing molecules at its core, and upon successful results from this study, Dimerix intends to pursue the pathway of registration of a product for an orphan indication. The study has been initiated at the Austin Hospital under the supervision of Professor Power, and is currently recruiting patients.

Category: Health & biotech
URL: http://dimerix.com/
Operational Status: Active
ASX Listing Code (if applicable):
Year of Commencement: 2004
Address:

Dimerix Bioscience Limited
PO Box 24231
Melbourne,VIC 3000
AUSTRALIA

State: Victoria, Western Australia
Overseas Operations: No
Twitter:
Facebook:
Linkedin: https://www.linkedin.com/company/dimerix-bioscience?trk=top_nav_home
Key Personnel:
Awards won:

Leave a Reply